Neurosteroid Binding Sites on the GABAA Receptor Complex as Novel Targets for Therapeutics to Reduce Alcohol Abuse and Dependence

Despite the prevalence of alcohol abuse and dependence in the US and Europe, there are only five approved pharmacotherapies for alcohol dependence. Moreover, these pharmacotherapeutic options have limited clinical utility. The purpose of this paper is to present pertinent literature suggesting that...

Full description

Saved in:
Bibliographic Details
Main Authors: Mary W. Hulin, Russell J. Amato, Johnny R. Porter, Catalin M. Filipeanu, Peter J. Winsauer
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Advances in Pharmacological Sciences
Online Access:http://dx.doi.org/10.1155/2011/926361
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841524594208407552
author Mary W. Hulin
Russell J. Amato
Johnny R. Porter
Catalin M. Filipeanu
Peter J. Winsauer
author_facet Mary W. Hulin
Russell J. Amato
Johnny R. Porter
Catalin M. Filipeanu
Peter J. Winsauer
author_sort Mary W. Hulin
collection DOAJ
description Despite the prevalence of alcohol abuse and dependence in the US and Europe, there are only five approved pharmacotherapies for alcohol dependence. Moreover, these pharmacotherapeutic options have limited clinical utility. The purpose of this paper is to present pertinent literature suggesting that both alcohol and the neurosteroids interact at the GABAA receptor complex and that the neurosteroid sites on this receptor complex could serve as new targets for the development of novel therapeutics for alcohol abuse. This paper will also present data collected by our laboratory showing that one neurosteroid in particular, dehydroepiandrosterone (DHEA), decreases ethanol intake in rats under a variety of conditions. In the process, we will also mention relevant studies from the literature suggesting that both particular subtypes and subunits of the GABAA receptor play an important role in mediating the interaction of neurosteroids and ethanol.
format Article
id doaj-art-f58b6d7a5d8c444fb1cb5412341dda07
institution Kabale University
issn 1687-6334
1687-6342
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Advances in Pharmacological Sciences
spelling doaj-art-f58b6d7a5d8c444fb1cb5412341dda072025-02-03T05:47:57ZengWileyAdvances in Pharmacological Sciences1687-63341687-63422011-01-01201110.1155/2011/926361926361Neurosteroid Binding Sites on the GABAA Receptor Complex as Novel Targets for Therapeutics to Reduce Alcohol Abuse and DependenceMary W. Hulin0Russell J. Amato1Johnny R. Porter2Catalin M. Filipeanu3Peter J. Winsauer4Department of Pharmacology and Experimental Therapeutics, LSU Health Sciences Center, 1901 Perdido Street, New Orleans, LA 70112-1393, USADepartment of Pharmacology and Experimental Therapeutics, LSU Health Sciences Center, 1901 Perdido Street, New Orleans, LA 70112-1393, USADepartment of Physiology, LSU Health Sciences Center, New Orleans, LA 70112-1393, USADepartment of Pharmacology and Experimental Therapeutics, LSU Health Sciences Center, 1901 Perdido Street, New Orleans, LA 70112-1393, USADepartment of Pharmacology and Experimental Therapeutics, LSU Health Sciences Center, 1901 Perdido Street, New Orleans, LA 70112-1393, USADespite the prevalence of alcohol abuse and dependence in the US and Europe, there are only five approved pharmacotherapies for alcohol dependence. Moreover, these pharmacotherapeutic options have limited clinical utility. The purpose of this paper is to present pertinent literature suggesting that both alcohol and the neurosteroids interact at the GABAA receptor complex and that the neurosteroid sites on this receptor complex could serve as new targets for the development of novel therapeutics for alcohol abuse. This paper will also present data collected by our laboratory showing that one neurosteroid in particular, dehydroepiandrosterone (DHEA), decreases ethanol intake in rats under a variety of conditions. In the process, we will also mention relevant studies from the literature suggesting that both particular subtypes and subunits of the GABAA receptor play an important role in mediating the interaction of neurosteroids and ethanol.http://dx.doi.org/10.1155/2011/926361
spellingShingle Mary W. Hulin
Russell J. Amato
Johnny R. Porter
Catalin M. Filipeanu
Peter J. Winsauer
Neurosteroid Binding Sites on the GABAA Receptor Complex as Novel Targets for Therapeutics to Reduce Alcohol Abuse and Dependence
Advances in Pharmacological Sciences
title Neurosteroid Binding Sites on the GABAA Receptor Complex as Novel Targets for Therapeutics to Reduce Alcohol Abuse and Dependence
title_full Neurosteroid Binding Sites on the GABAA Receptor Complex as Novel Targets for Therapeutics to Reduce Alcohol Abuse and Dependence
title_fullStr Neurosteroid Binding Sites on the GABAA Receptor Complex as Novel Targets for Therapeutics to Reduce Alcohol Abuse and Dependence
title_full_unstemmed Neurosteroid Binding Sites on the GABAA Receptor Complex as Novel Targets for Therapeutics to Reduce Alcohol Abuse and Dependence
title_short Neurosteroid Binding Sites on the GABAA Receptor Complex as Novel Targets for Therapeutics to Reduce Alcohol Abuse and Dependence
title_sort neurosteroid binding sites on the gabaa receptor complex as novel targets for therapeutics to reduce alcohol abuse and dependence
url http://dx.doi.org/10.1155/2011/926361
work_keys_str_mv AT marywhulin neurosteroidbindingsitesonthegabaareceptorcomplexasnoveltargetsfortherapeuticstoreducealcoholabuseanddependence
AT russelljamato neurosteroidbindingsitesonthegabaareceptorcomplexasnoveltargetsfortherapeuticstoreducealcoholabuseanddependence
AT johnnyrporter neurosteroidbindingsitesonthegabaareceptorcomplexasnoveltargetsfortherapeuticstoreducealcoholabuseanddependence
AT catalinmfilipeanu neurosteroidbindingsitesonthegabaareceptorcomplexasnoveltargetsfortherapeuticstoreducealcoholabuseanddependence
AT peterjwinsauer neurosteroidbindingsitesonthegabaareceptorcomplexasnoveltargetsfortherapeuticstoreducealcoholabuseanddependence